Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Harmony Biosciences Holdings (HRMY) Change in Acquisitions & Divestments (2022 - 2025)

Historic Change in Acquisitions & Divestments for Harmony Biosciences Holdings (HRMY) over the last 4 years, with Q3 2025 value amounting to $19.6 million.

  • Harmony Biosciences Holdings' Change in Acquisitions & Divestments fell 1860.62% to $19.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $90.5 million, marking a year-over-year decrease of 68.8%. This contributed to the annual value of $98.5 million for FY2024, which is 1672.06% down from last year.
  • Harmony Biosciences Holdings' Change in Acquisitions & Divestments amounted to $19.6 million in Q3 2025, which was down 1860.62% from $19.3 million recorded in Q2 2025.
  • Harmony Biosciences Holdings' Change in Acquisitions & Divestments' 5-year high stood at $46.0 million during Q1 2023, with a 5-year trough of $8.2 million in Q4 2022.
  • For the 4-year period, Harmony Biosciences Holdings' Change in Acquisitions & Divestments averaged around $23.8 million, with its median value being $22.1 million (2023).
  • As far as peak fluctuations go, Harmony Biosciences Holdings' Change in Acquisitions & Divestments soared by 17597.9% in 2023, and later plummeted by 5884.62% in 2024.
  • Harmony Biosciences Holdings' Change in Acquisitions & Divestments (Quarter) stood at $8.2 million in 2022, then surged by 175.98% to $22.6 million in 2023, then surged by 32.66% to $30.0 million in 2024, then tumbled by 34.81% to $19.6 million in 2025.
  • Its last three reported values are $19.6 million in Q3 2025, $19.3 million for Q2 2025, and $21.6 million during Q1 2025.